HTA134 The Impact of Non-Comparative Data for Non-Orphan Drugs on HTA and Pricing Outcomes in Germany: Can an Added Benefit Ever be Proven?
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1818
https://www.valueinhealthjournal.com/article/S1098-3015(23)04948-3/fulltext
Title :
HTA134 The Impact of Non-Comparative Data for Non-Orphan Drugs on HTA and Pricing Outcomes in Germany: Can an Added Benefit Ever be Proven?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04948-3&doi=10.1016/j.jval.2023.09.1818
First page :
Section Title :
Open access? :
No
Section Order :
11258